NRGN and Alzheimer disease: In terms of disease progression along the AD continuum, increasing levels of CSF Ng have been found to be an indicator of disease stage in several studies [12, 56, 57] and meta-analyses [58, 59], with Ng levels showing reliable increases with greater disease severity, peaking in patients with AD dementia.